disopyramide has been researched along with Cardiomyopathies in 10 studies
Disopyramide: A class I anti-arrhythmic agent (one that interferes directly with the depolarization of the cardiac membrane and thus serves as a membrane-stabilizing agent) with a depressant action on the heart similar to that of guanidine. It also possesses some anticholinergic and local anesthetic properties.
disopyramide : A monocarboxylic acid amide that is butanamide substituted by a diisopropylamino group at position 4, a phenyl group at position 2 and a pyridin-2-yl group at position 2. It is used as a anti-arrhythmia drug.
Cardiomyopathies: A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).
| Excerpt | Relevance | Reference |
|---|---|---|
| "A patient with ischemic cardiomyopathy and congestive heart failure was treated with disopyramide phosphate for ventricular arrhythmias." | 7.66 | Disopyramide-induced ventricular tachycardia. ( Gantz, KB; Lo, KS; Lucchesi, BR; Pitt, B; Stetson, PL, 1980) |
| " Sustained rapid ventricular tachyarrhythmias requiring cardioversion for termination were induced by double right ventricular apical extrastimuli during control, and treatment with disopyramide, quinidine, and fluocortolone." | 3.67 | Failure of corticosteroid therapy to prevent induction of ventricular tachycardia in sarcoidosis. ( Belhassen, B; Laniado, S; Pines, A, 1989) |
| "A patient with ischemic cardiomyopathy and congestive heart failure was treated with disopyramide phosphate for ventricular arrhythmias." | 3.66 | Disopyramide-induced ventricular tachycardia. ( Gantz, KB; Lo, KS; Lucchesi, BR; Pitt, B; Stetson, PL, 1980) |
| "Monomorphic sustained ventricular tachycardia (MSVT) was revisited in relation to the electrophysiologic findings and their relation to the drug efficacy." | 2.40 | Reentrant ventricular tachycardia. Interpretations of electrophysiologic findings and its applications. ( Aizawa, Y; Tanabe, Y; Yamaura, M, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (60.00) | 18.7374 |
| 1990's | 3 (30.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Philippakis, AA | 1 |
| Falk, RH | 1 |
| Lo, KS | 1 |
| Gantz, KB | 1 |
| Stetson, PL | 1 |
| Lucchesi, BR | 1 |
| Pitt, B | 1 |
| Sevick, RJ | 1 |
| Wyse, DG | 1 |
| Wolff, GS | 1 |
| Aizawa, Y | 1 |
| Tanabe, Y | 1 |
| Yamaura, M | 1 |
| Albanesi Filho, FM | 1 |
| da Rocha, PJ | 1 |
| Benchimol, CB | 1 |
| Ginefra, P | 1 |
| Benchimol, AB | 1 |
| Sumimoto, T | 1 |
| Hamada, M | 1 |
| Ohtani, T | 1 |
| Suzuki, M | 1 |
| Abe, M | 1 |
| Matsuoka, H | 1 |
| Fujiwara, Y | 1 |
| Sekiya, M | 1 |
| Hiwada, K | 1 |
| You, S | 1 |
| Miyazaki, T | 1 |
| Noya, K | 1 |
| Ogawa, S | 1 |
| Nakamura, Y | 1 |
| Belhassen, B | 1 |
| Pines, A | 1 |
| Laniado, S | 1 |
| Kasanuki, H | 1 |
| Onishi, S | 1 |
| Hirosawa, K | 1 |
2 reviews available for disopyramide and Cardiomyopathies
| Article | Year |
|---|---|
Unexplained syncope: clinical management.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Adult; Anti-Arrhythmia Agents; Behavior Ther | 1997 |
Reentrant ventricular tachycardia. Interpretations of electrophysiologic findings and its applications.
Topics: Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Cardiomyopathies; Disopyramide; Electrocardiogra | 1998 |
8 other studies available for disopyramide and Cardiomyopathies
| Article | Year |
|---|---|
Cardiac amyloidosis mimicking hypertrophic cardiomyopathy with obstruction: treatment with disopyramide.
Topics: Aged; Amyloidosis; Cardiomyopathies; Cardiomyopathy, Hypertrophic; Disopyramide; Humans; Magnetic Re | 2012 |
Disopyramide-induced ventricular tachycardia.
Topics: Alcoholism; Cardiac Complexes, Premature; Cardiomyopathies; Coronary Disease; Disopyramide; Heart Fa | 1980 |
Long-term management of arrhythmogenic right ventricular dysplasia.
Topics: Adolescent; Cardiomegaly; Cardiomyopathies; Disopyramide; Electrocardiography; Heart Ventricles; Hum | 1983 |
[Disopyramide in the treatment of ventricular extrasystole in chronic Chagas' disease].
Topics: Adult; Cardiac Complexes, Premature; Cardiomyopathies; Chagas Disease; Disopyramide; Electrocardiogr | 1979 |
Effect of disopyramide on left ventricular diastolic function in patients with hypertrophic cardiomyopathy: comparison with diltiazem.
Topics: Adult; Aged; Blood Pressure; Cardiomegaly; Cardiomyopathies; Diltiazem; Disopyramide; Echocardiograp | 1992 |
[Antiarrhythmic drug therapy for arrhythmogenic right ventricular dysplasia].
Topics: Adult; Cardiac Catheterization; Cardiomyopathies; Disopyramide; Drug Evaluation; Echocardiography; E | 1989 |
Failure of corticosteroid therapy to prevent induction of ventricular tachycardia in sarcoidosis.
Topics: Adult; Amiodarone; Cardiac Pacing, Artificial; Cardiomyopathies; Disopyramide; Drug Therapy, Combina | 1989 |
The usefulness of electrophysiological-pharmacologic studies in the long-term therapy of paroxysmal tachycardias.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Arrhythmia Agents; Cardiomyopathies; Chromatogra | 1985 |